MAPK9, JNK2, PRKM9, Mitogen-activated protein kinase 9, Stress-activated protein kinase JNK2;c-Jun N-terminal kinase 2;JNK-55
Key Feature
Clonality
Monoclonal
Clone Number
EP1595Y
Host Species
Rabbit
Tested Applications
WBIHC
WB:1:500 IHC
Species Reactivity
Human
Concentration
1mg/ml
Target Information
Gene Synonyms
JNK2 PRKM9 SAPK1A
Alternative Names
MAPK9 JNK2 PRKM9 Mitogen-activated protein kinase 9 Stress-activated protein kinase JNK2 c-Jun N-terminal kinase 2 JNK-55
Molecular Weight(MW)
48139 Da
Function
Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2 In turn, MAPK9/JNK2 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. In response to oxidative or ribotoxic stresses, inhibits rRNA synthesis by phosphorylating and inactivating the RNA polymerase 1-specific transcription initiation factor RRN3. Promotes stressed cell apoptosis by phosphorylating key regulatory factors including TP53 and YAP1. In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Upon T-cell receptor (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and MAP3K7/TAK1 to regulate JUN protein levels. Plays an important role in the osmotic stress-induced epithelial tight-junctions disruption. When activated, promotes beta-catenin/CTNNB1 degradation and inhibits the canonical Wnt signaling pathway Participates also in neurite growth in spiral ganglion neurons
Tissue Specificity
A synthetic peptide corresponding to residues near the C-terminus of human JNK2 was used as an immunogen.